Cargando…
Biomarkers of COVID-19 and technologies to combat SARS-CoV-2
Due to the unprecedented public health crisis caused by COVID-19, our first contribution to the newly launching journal, Advances in Biomarker Sciences and Technology, has abruptly diverted to focus on the current pandemic. As the number of new COVID-19 cases and deaths continue to rise steadily aro...
Autores principales: | Zhang, Luoping, Guo, Helen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435336/ https://www.ncbi.nlm.nih.gov/pubmed/33511330 http://dx.doi.org/10.1016/j.abst.2020.08.001 |
Ejemplares similares
-
Commercialized diagnostic technologies to combat SARS-CoV2: Advantages and disadvantages
por: Pérez-López, Briza, et al.
Publicado: (2021) -
RNAi Technology and Investigation on Possible Vaccines to Combat SARS-CoV-2 Infection
por: Talukder, Pratik, et al.
Publicado: (2021) -
SARS-CoV-2: Combating Coronavirus Emergence
por: Graham, Rachel L., et al.
Publicado: (2020) -
Understanding and combating COVID-19 using the biology and chemistry of SARS-CoV-2
por: Khan, Mohammad Mansoob, et al.
Publicado: (2022) -
Therapeutic significance of nano- and biosensor technology in combating SARS-CoV-2: a review
por: Abid, Rameesha, et al.
Publicado: (2022)